imho most of the screening programs will be government directed and driven. the estimates for costs / deaths of colorectal cancer treatment - for Aus alone comes in at just over $8.5 billion (say 17 yr period) not including loss of life intangibles. I query whether marketing spend will be in issue. for example the cervical cancer screening program simply tells the GP's what process to use (recently changed from Pap smear program to a DNA cytology based program) this has no marketing it was simply government directive because it was superior. I anticipate agreements with govt as national screening program partners as opposed to driven by marketing spend
- Forums
- ASX - By Stock
- RHY
- Ann: CE Mark Granted for ColoSTAT
Ann: CE Mark Granted for ColoSTAT, page-33
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.14M |
Open | High | Low | Value | Volume |
7.3¢ | 7.3¢ | 7.3¢ | $2.461K | 33.71K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 414 | 7.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.6¢ | 13853 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 414 | 0.073 |
1 | 6387 | 0.070 |
1 | 18784 | 0.065 |
1 | 35000 | 0.064 |
1 | 100000 | 0.062 |
Price($) | Vol. | No. |
---|---|---|
0.076 | 13853 | 4 |
0.077 | 12974 | 1 |
0.080 | 1140 | 1 |
0.084 | 43251 | 2 |
0.085 | 17407 | 1 |
Last trade - 13.35pm 27/09/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |